The localization of α-synuclein in the process of differentiation of human erythroid cells
暂无分享,去创建一个
N. Takahashi | Kumi Ubukawa | W. Nunomura | K. Sawada | H. Mochizuki | E. Hayakawa | H. Wakui | Katsuya Araki | Kotomi Sugawara | Isuzu Kobayashi
[1] R. Heeren,et al. The Impact of N-terminal Acetylation of α-Synuclein on Phospholipid Membrane Binding and Fibril Structure* , 2016, The Journal of Biological Chemistry.
[2] N. Yagi,et al. A small-angle X-ray scattering study of alpha-synuclein from human red blood cells , 2016, Scientific Reports.
[3] N. Takahashi,et al. Erythroblast enucleation is a dynein-dependent process. , 2016, Experimental hematology.
[4] C. Harding,et al. A critical role for alpha-synuclein in development and function of T lymphocytes. , 2016, Immunobiology.
[5] H. Harigae,et al. Biology of Heme in Mammalian Erythroid Cells and Related Disorders , 2015, BioMed research international.
[6] S. Juul,et al. Erythropoietin and Neonatal Neuroprotection. , 2015, Clinics in perinatology.
[7] M. Palmgren,et al. Structure and mechanism of ATP-dependent phospholipid transporters. , 2015, Biochimica et biophysica acta.
[8] D. Eliezer,et al. Alpha-Synuclein Function and Dysfunction on Cellular Membranes , 2014, Experimental neurobiology.
[9] V. Subramaniam,et al. Membrane interactions and fibrillization of α‐synuclein play an essential role in membrane disruption , 2014, FEBS letters.
[10] C. Harding,et al. Late stages of hematopoiesis and B cell lymphopoiesis are regulated by α-synuclein, a key player in Parkinson's disease. , 2014, Immunobiology.
[11] Ken Nakamura. α-Synuclein and Mitochondria: Partners in Crime? , 2013, Neurotherapeutics.
[12] H. Lashuel,et al. Characterization of Semisynthetic and Naturally Nα-Acetylated α-Synuclein in Vitro and in Intact Cells , 2012, The Journal of Biological Chemistry.
[13] D. Eliezer,et al. Folding and misfolding of alpha-synuclein on membranes. , 2012, Biochimica et biophysica acta.
[14] H. Tagawa,et al. Enucleation of human erythroblasts involves non-muscle myosin IIB. , 2012, Blood.
[15] D. Selkoe,et al. α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation , 2011, Nature.
[16] W. Jelkmann. Regulation of erythropoietin production , 2011, The Journal of physiology.
[17] K. Kinoshita,et al. Similarities and differences in the structure and function of 4.1G and 4.1R135, two protein 4.1 paralogues expressed in erythroid cells. , 2010, The Biochemical journal.
[18] N. Mohandas,et al. ATP-dependent Mechanism Protects Spectrin against Glycation in Human Erythrocytes* , 2010, The Journal of Biological Chemistry.
[19] J. Trojanowski,et al. Exogenous α-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells , 2009, Proceedings of the National Academy of Sciences.
[20] Takehiko Sasaki,et al. Dynamics of human erythroblast enucleation , 2008, International journal of hematology.
[21] Erika K Wallender,et al. Optical Reporters for the Conformation of α-Synuclein Reveal a Specific Interaction with Mitochondria , 2008, The Journal of Neuroscience.
[22] A. Eklund,et al. GATA transcription factors directly regulate the Parkinson's disease-linked gene α-synuclein , 2008, Proceedings of the National Academy of Sciences.
[23] R. Barbour,et al. Red Blood Cells Are the Major Source of Alpha-Synuclein in Blood , 2008, Neurodegenerative Diseases.
[24] V. Hackley,et al. A Mycobacterium tuberculosis-derived lipid inhibits membrane fusion by modulating lipid membrane domains. , 2007, Biophysical journal.
[25] Makoto Hashimoto,et al. Expression of alpha-synuclein, a presynaptic protein implicated in Parkinson's disease, in erythropoietic lineage. , 2007, Biochemical and biophysical research communications.
[26] Seung-Jae Lee,et al. Membrane-bound α-Synuclein Has a High Aggregation Propensity and the Ability to Seed the Aggregation of the Cytosolic Form* , 2002, The Journal of Biological Chemistry.
[27] Nigel J. Cairns,et al. Filamentous α-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies , 1998, Neuroscience Letters.
[28] R. Crowther,et al. α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies , 1998 .
[29] J Q Trojanowski,et al. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. , 1998, The American journal of pathology.
[30] R. Scheller,et al. Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[31] C. Civin,et al. Purification of human erythroid colony-forming units and demonstration of specific binding of erythropoietin. , 1987, The Journal of clinical investigation.
[32] A. Giese,et al. Interaction of α-synuclein with biomembranes in Parkinson's disease--role of cardiolipin. , 2016, Progress in lipid research.
[33] R. Fock,et al. Erythropoiesis in vertebrates: from ontogeny to clinical relevance. , 2016, Frontiers in bioscience.
[34] N. Mohandas,et al. Marked difference in membrane-protein-binding properties of the two isoforms of protein 4.1R expressed at early and late stages of erythroid differentiation. , 2009, The Biochemical journal.
[35] 김종선. On the mechanism of internalization of alpha-synuclein into microglia: roles of ganglioside GM1 and lipid raft , 2009 .
[36] R A Crowther,et al. Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies. , 1998, Neuroscience letters.
[37] C. Reutelingsperger,et al. Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. , 1998, Cytometry.